Kayla Campbell

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine”.

Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine

Clinical Infectious Diseases(2021)10.1093/cid/ciab1037

N/A

0.365DataRank · unranked

5 citations

Michelle Pham, Erin Sizemore, Neil Martinson, Wadzanai Samaneka, Lerato Mohapi +20 more

Antifungal liposomes: Lipid saturation and cholesterol concentration impact interaction with fungal and mammalian cells

Journal of Biomedical Materials Research Part A(2023)10.1002/jbm.a.37501

N/A

0DataRank · unranked

17 citations

Kayla Campbell, P. Gonzalez, Tobias Meng‐Saccoccio, Anita Shukla, Veronica LaMastro

Triggered Antifungal Therapy via Candida ‐Responsive Hydrogels

Advanced Therapeutics(2025)10.1002/adtp.202500415

N/A

0DataRank · unranked

0 citations

Serly Chohmalian, Kayla Campbell, Anita Shukla, Caio Cesar Carvalho